1261. Antimicrobial Activity of Aztreonam-Avibactam against Gram-negative Bacteria Isolated from Patients Hospitalized with Pneumonia in Europe, Latin America, and Asia in 2019

BACKGROUND: Aztreonam (ATM) is a monobactam stable to hydrolysis by metallo-β-lactamases (MBL). Avibactam (AVI) is a non-β-lactam β-lactamase inhibitor that inhibits serine carbapenemases (CPEs), such as ESBLs, KPCs, AmpC, and some OXAs. ATM-AVI is under clinical development for treatment of serious...

Descripción completa

Detalles Bibliográficos
Autores principales: Sader, Helio S, Castanheira, Mariana, Carvalhaes, Cecilia G, Doyle, Timothy B, Mendes, Rodrigo E
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2020
Materias:
Poster Abstracts
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7776761/
http://dx.doi.org/10.1093/ofid/ofaa439.1445

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7776761/
http://dx.doi.org/10.1093/ofid/ofaa439.1445

Ejemplares similares